ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biomarker Testing for Cancer Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-8F10612
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biomarker Testing for Cancer Market Research Report 2022
BUY CHAPTERS

Global Biomarker Testing for Cancer Market Research Report 2025

Code: QYRE-Auto-8F10612
Report
March 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
F. Hoffmann-L a Roche
Thermo Fisher Scientific
QIAGEN N V
llumina
Bio-Rad L aboratories

Biomarker Testing for Cancer Market

The global market for Biomarker Testing for Cancer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cancer markers refer to substances directly produced by tumor cells or induced by non-tumor cells through tumor cells.
North American market for Biomarker Testing for Cancer is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biomarker Testing for Cancer is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Biomarker Testing for Cancer include F. Hoffmann-L A Roche, Thermo Fisher Scientific, Qiagen N.V., Bio-Rad L aboratories, llumina, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biomarker Testing for Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker Testing for Cancer.
The Biomarker Testing for Cancer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biomarker Testing for Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarker Testing for Cancer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Biomarker Testing for Cancer Market Report

Report Metric Details
Report Name Biomarker Testing for Cancer Market
Segment by Type
Segment by Application
  • Diagnostics
  • Research & Development
  • Prognostics
  • Risk Assessment
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company F. Hoffmann-L A Roche, Thermo Fisher Scientific, Qiagen N.V., Bio-Rad L aboratories, llumina
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Biomarker Testing for Cancer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Biomarker Testing for Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Biomarker Testing for Cancer Market report?

Ans: The main players in the Biomarker Testing for Cancer Market are F. Hoffmann-L A Roche, Thermo Fisher Scientific, Qiagen N.V., Bio-Rad L aboratories, llumina

What are the Application segmentation covered in the Biomarker Testing for Cancer Market report?

Ans: The Applications covered in the Biomarker Testing for Cancer Market report are Diagnostics, Research & Development, Prognostics, Risk Assessment, Others

What are the Type segmentation covered in the Biomarker Testing for Cancer Market report?

Ans: The Types covered in the Biomarker Testing for Cancer Market report are Protein Biomarkers, Genetic Biomarkers, Others

Recommended Reports

Cancer Diagnostics

Biomarker & Testing

Specialized Cancer Tests

1 Biomarker Testing for Cancer Market Overview
1.1 Product Definition
1.2 Biomarker Testing for Cancer by Type
1.2.1 Global Biomarker Testing for Cancer Market Value Comparison by Type (2024 VS 2031)
1.2.2 Protein Biomarkers
1.2.3 Genetic Biomarkers
1.2.4 Others
1.3 Biomarker Testing for Cancer by Application
1.3.1 Global Biomarker Testing for Cancer Market Value by Application (2024 VS 2031)
1.3.2 Diagnostics
1.3.3 Research & Development
1.3.4 Prognostics
1.3.5 Risk Assessment
1.3.6 Others
1.4 Global Biomarker Testing for Cancer Market Size Estimates and Forecasts
1.4.1 Global Biomarker Testing for Cancer Revenue 2020-2031
1.4.2 Global Biomarker Testing for Cancer Sales 2020-2031
1.4.3 Global Biomarker Testing for Cancer Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Biomarker Testing for Cancer Market Competition by Manufacturers
2.1 Global Biomarker Testing for Cancer Sales Market Share by Manufacturers (2020-2025)
2.2 Global Biomarker Testing for Cancer Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Biomarker Testing for Cancer Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Biomarker Testing for Cancer, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biomarker Testing for Cancer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biomarker Testing for Cancer, Product Type & Application
2.7 Global Key Manufacturers of Biomarker Testing for Cancer, Date of Enter into This Industry
2.8 Global Biomarker Testing for Cancer Market Competitive Situation and Trends
2.8.1 Global Biomarker Testing for Cancer Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biomarker Testing for Cancer Players Market Share by Revenue
2.8.3 Global Biomarker Testing for Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biomarker Testing for Cancer Market Scenario by Region
3.1 Global Biomarker Testing for Cancer Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Biomarker Testing for Cancer Sales by Region: 2020-2031
3.2.1 Global Biomarker Testing for Cancer Sales by Region: 2020-2025
3.2.2 Global Biomarker Testing for Cancer Sales by Region: 2026-2031
3.3 Global Biomarker Testing for Cancer Revenue by Region: 2020-2031
3.3.1 Global Biomarker Testing for Cancer Revenue by Region: 2020-2025
3.3.2 Global Biomarker Testing for Cancer Revenue by Region: 2026-2031
3.4 North America Biomarker Testing for Cancer Market Facts & Figures by Country
3.4.1 North America Biomarker Testing for Cancer Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Biomarker Testing for Cancer Sales by Country (2020-2031)
3.4.3 North America Biomarker Testing for Cancer Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Biomarker Testing for Cancer Market Facts & Figures by Country
3.5.1 Europe Biomarker Testing for Cancer Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Biomarker Testing for Cancer Sales by Country (2020-2031)
3.5.3 Europe Biomarker Testing for Cancer Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biomarker Testing for Cancer Market Facts & Figures by Region
3.6.1 Asia Pacific Biomarker Testing for Cancer Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Biomarker Testing for Cancer Sales by Region (2020-2031)
3.6.3 Asia Pacific Biomarker Testing for Cancer Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Biomarker Testing for Cancer Market Facts & Figures by Country
3.7.1 Latin America Biomarker Testing for Cancer Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Biomarker Testing for Cancer Sales by Country (2020-2031)
3.7.3 Latin America Biomarker Testing for Cancer Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biomarker Testing for Cancer Market Facts & Figures by Country
3.8.1 Middle East and Africa Biomarker Testing for Cancer Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Biomarker Testing for Cancer Sales by Country (2020-2031)
3.8.3 Middle East and Africa Biomarker Testing for Cancer Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Biomarker Testing for Cancer Sales by Type (2020-2031)
4.1.1 Global Biomarker Testing for Cancer Sales by Type (2020-2025)
4.1.2 Global Biomarker Testing for Cancer Sales by Type (2026-2031)
4.1.3 Global Biomarker Testing for Cancer Sales Market Share by Type (2020-2031)
4.2 Global Biomarker Testing for Cancer Revenue by Type (2020-2031)
4.2.1 Global Biomarker Testing for Cancer Revenue by Type (2020-2025)
4.2.2 Global Biomarker Testing for Cancer Revenue by Type (2026-2031)
4.2.3 Global Biomarker Testing for Cancer Revenue Market Share by Type (2020-2031)
4.3 Global Biomarker Testing for Cancer Price by Type (2020-2031)
5 Segment by Application
5.1 Global Biomarker Testing for Cancer Sales by Application (2020-2031)
5.1.1 Global Biomarker Testing for Cancer Sales by Application (2020-2025)
5.1.2 Global Biomarker Testing for Cancer Sales by Application (2026-2031)
5.1.3 Global Biomarker Testing for Cancer Sales Market Share by Application (2020-2031)
5.2 Global Biomarker Testing for Cancer Revenue by Application (2020-2031)
5.2.1 Global Biomarker Testing for Cancer Revenue by Application (2020-2025)
5.2.2 Global Biomarker Testing for Cancer Revenue by Application (2026-2031)
5.2.3 Global Biomarker Testing for Cancer Revenue Market Share by Application (2020-2031)
5.3 Global Biomarker Testing for Cancer Price by Application (2020-2031)
6 Key Companies Profiled
6.1 F. Hoffmann-L A Roche
6.1.1 F. Hoffmann-L A Roche Company Information
6.1.2 F. Hoffmann-L A Roche Description and Business Overview
6.1.3 F. Hoffmann-L A Roche Biomarker Testing for Cancer Sales, Revenue and Gross Margin (2020-2025)
6.1.4 F. Hoffmann-L A Roche Biomarker Testing for Cancer Product Portfolio
6.1.5 F. Hoffmann-L A Roche Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Biomarker Testing for Cancer Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Thermo Fisher Scientific Biomarker Testing for Cancer Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Qiagen N.V.
6.3.1 Qiagen N.V. Company Information
6.3.2 Qiagen N.V. Description and Business Overview
6.3.3 Qiagen N.V. Biomarker Testing for Cancer Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Qiagen N.V. Biomarker Testing for Cancer Product Portfolio
6.3.5 Qiagen N.V. Recent Developments/Updates
6.4 Bio-Rad L aboratories
6.4.1 Bio-Rad L aboratories Company Information
6.4.2 Bio-Rad L aboratories Description and Business Overview
6.4.3 Bio-Rad L aboratories Biomarker Testing for Cancer Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bio-Rad L aboratories Biomarker Testing for Cancer Product Portfolio
6.4.5 Bio-Rad L aboratories Recent Developments/Updates
6.5 llumina
6.5.1 llumina Company Information
6.5.2 llumina Description and Business Overview
6.5.3 llumina Biomarker Testing for Cancer Sales, Revenue and Gross Margin (2020-2025)
6.5.4 llumina Biomarker Testing for Cancer Product Portfolio
6.5.5 llumina Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biomarker Testing for Cancer Industry Chain Analysis
7.2 Biomarker Testing for Cancer Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biomarker Testing for Cancer Production Mode & Process Analysis
7.4 Biomarker Testing for Cancer Sales and Marketing
7.4.1 Biomarker Testing for Cancer Sales Channels
7.4.2 Biomarker Testing for Cancer Distributors
7.5 Biomarker Testing for Cancer Customer Analysis
8 Biomarker Testing for Cancer Market Dynamics
8.1 Biomarker Testing for Cancer Industry Trends
8.2 Biomarker Testing for Cancer Market Drivers
8.3 Biomarker Testing for Cancer Market Challenges
8.4 Biomarker Testing for Cancer Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
F. Hoffmann-L a Roche
Thermo Fisher Scientific
QIAGEN N V
llumina
Bio-Rad L aboratories
List of Tables
 Table 1. Global Biomarker Testing for Cancer Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Biomarker Testing for Cancer Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Biomarker Testing for Cancer Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Biomarker Testing for Cancer Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Biomarker Testing for Cancer Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Biomarker Testing for Cancer Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Biomarker Testing for Cancer Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Biomarker Testing for Cancer Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Biomarker Testing for Cancer, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Biomarker Testing for Cancer, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Biomarker Testing for Cancer, Product Type & Application
 Table 12. Global Key Manufacturers of Biomarker Testing for Cancer, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Biomarker Testing for Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker Testing for Cancer as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Biomarker Testing for Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Biomarker Testing for Cancer Sales by Region (2020-2025) & (K Units)
 Table 18. Global Biomarker Testing for Cancer Sales Market Share by Region (2020-2025)
 Table 19. Global Biomarker Testing for Cancer Sales by Region (2026-2031) & (K Units)
 Table 20. Global Biomarker Testing for Cancer Sales Market Share by Region (2026-2031)
 Table 21. Global Biomarker Testing for Cancer Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Biomarker Testing for Cancer Revenue Market Share by Region (2020-2025)
 Table 23. Global Biomarker Testing for Cancer Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Biomarker Testing for Cancer Revenue Market Share by Region (2026-2031)
 Table 25. North America Biomarker Testing for Cancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Biomarker Testing for Cancer Sales by Country (2020-2025) & (K Units)
 Table 27. North America Biomarker Testing for Cancer Sales by Country (2026-2031) & (K Units)
 Table 28. North America Biomarker Testing for Cancer Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Biomarker Testing for Cancer Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Biomarker Testing for Cancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Biomarker Testing for Cancer Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Biomarker Testing for Cancer Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Biomarker Testing for Cancer Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Biomarker Testing for Cancer Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Biomarker Testing for Cancer Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Biomarker Testing for Cancer Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Biomarker Testing for Cancer Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Biomarker Testing for Cancer Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Biomarker Testing for Cancer Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Biomarker Testing for Cancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Biomarker Testing for Cancer Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Biomarker Testing for Cancer Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Biomarker Testing for Cancer Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Biomarker Testing for Cancer Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Biomarker Testing for Cancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Biomarker Testing for Cancer Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Biomarker Testing for Cancer Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Biomarker Testing for Cancer Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Biomarker Testing for Cancer Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Biomarker Testing for Cancer Sales (K Units) by Type (2020-2025)
 Table 51. Global Biomarker Testing for Cancer Sales (K Units) by Type (2026-2031)
 Table 52. Global Biomarker Testing for Cancer Sales Market Share by Type (2020-2025)
 Table 53. Global Biomarker Testing for Cancer Sales Market Share by Type (2026-2031)
 Table 54. Global Biomarker Testing for Cancer Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Biomarker Testing for Cancer Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Biomarker Testing for Cancer Revenue Market Share by Type (2020-2025)
 Table 57. Global Biomarker Testing for Cancer Revenue Market Share by Type (2026-2031)
 Table 58. Global Biomarker Testing for Cancer Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Biomarker Testing for Cancer Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Biomarker Testing for Cancer Sales (K Units) by Application (2020-2025)
 Table 61. Global Biomarker Testing for Cancer Sales (K Units) by Application (2026-2031)
 Table 62. Global Biomarker Testing for Cancer Sales Market Share by Application (2020-2025)
 Table 63. Global Biomarker Testing for Cancer Sales Market Share by Application (2026-2031)
 Table 64. Global Biomarker Testing for Cancer Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Biomarker Testing for Cancer Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Biomarker Testing for Cancer Revenue Market Share by Application (2020-2025)
 Table 67. Global Biomarker Testing for Cancer Revenue Market Share by Application (2026-2031)
 Table 68. Global Biomarker Testing for Cancer Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Biomarker Testing for Cancer Price (US$/Unit) by Application (2026-2031)
 Table 70. F. Hoffmann-L A Roche Company Information
 Table 71. F. Hoffmann-L A Roche Description and Business Overview
 Table 72. F. Hoffmann-L A Roche Biomarker Testing for Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. F. Hoffmann-L A Roche Biomarker Testing for Cancer Product
 Table 74. F. Hoffmann-L A Roche Recent Developments/Updates
 Table 75. Thermo Fisher Scientific Company Information
 Table 76. Thermo Fisher Scientific Description and Business Overview
 Table 77. Thermo Fisher Scientific Biomarker Testing for Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Thermo Fisher Scientific Biomarker Testing for Cancer Product
 Table 79. Thermo Fisher Scientific Recent Developments/Updates
 Table 80. Qiagen N.V. Company Information
 Table 81. Qiagen N.V. Description and Business Overview
 Table 82. Qiagen N.V. Biomarker Testing for Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Qiagen N.V. Biomarker Testing for Cancer Product
 Table 84. Qiagen N.V. Recent Developments/Updates
 Table 85. Bio-Rad L aboratories Company Information
 Table 86. Bio-Rad L aboratories Description and Business Overview
 Table 87. Bio-Rad L aboratories Biomarker Testing for Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Bio-Rad L aboratories Biomarker Testing for Cancer Product
 Table 89. Bio-Rad L aboratories Recent Developments/Updates
 Table 90. llumina Company Information
 Table 91. llumina Description and Business Overview
 Table 92. llumina Biomarker Testing for Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. llumina Biomarker Testing for Cancer Product
 Table 94. llumina Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Biomarker Testing for Cancer Distributors List
 Table 98. Biomarker Testing for Cancer Customers List
 Table 99. Biomarker Testing for Cancer Market Trends
 Table 100. Biomarker Testing for Cancer Market Drivers
 Table 101. Biomarker Testing for Cancer Market Challenges
 Table 102. Biomarker Testing for Cancer Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Biomarker Testing for Cancer
 Figure 2. Global Biomarker Testing for Cancer Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biomarker Testing for Cancer Market Share by Type: 2024 & 2031
 Figure 4. Protein Biomarkers Product Picture
 Figure 5. Genetic Biomarkers Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Biomarker Testing for Cancer Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Biomarker Testing for Cancer Market Share by Application: 2024 & 2031
 Figure 9. Diagnostics
 Figure 10. Research & Development
 Figure 11. Prognostics
 Figure 12. Risk Assessment
 Figure 13. Others
 Figure 14. Global Biomarker Testing for Cancer Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Biomarker Testing for Cancer Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Biomarker Testing for Cancer Sales (2020-2031) & (K Units)
 Figure 17. Global Biomarker Testing for Cancer Average Price (US$/Unit) & (2020-2031)
 Figure 18. Biomarker Testing for Cancer Report Years Considered
 Figure 19. Biomarker Testing for Cancer Sales Share by Manufacturers in 2024
 Figure 20. Global Biomarker Testing for Cancer Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Biomarker Testing for Cancer Players: Market Share by Revenue in Biomarker Testing for Cancer in 2024
 Figure 22. Biomarker Testing for Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Biomarker Testing for Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Biomarker Testing for Cancer Sales Market Share by Country (2020-2031)
 Figure 25. North America Biomarker Testing for Cancer Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Biomarker Testing for Cancer Sales Market Share by Country (2020-2031)
 Figure 29. Europe Biomarker Testing for Cancer Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Biomarker Testing for Cancer Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Biomarker Testing for Cancer Revenue Market Share by Region (2020-2031)
 Figure 37. China Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Biomarker Testing for Cancer Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Biomarker Testing for Cancer Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Biomarker Testing for Cancer Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Biomarker Testing for Cancer Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Biomarker Testing for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Biomarker Testing for Cancer by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Biomarker Testing for Cancer by Type (2020-2031)
 Figure 59. Global Biomarker Testing for Cancer Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Biomarker Testing for Cancer by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Biomarker Testing for Cancer by Application (2020-2031)
 Figure 62. Global Biomarker Testing for Cancer Price (US$/Unit) by Application (2020-2031)
 Figure 63. Biomarker Testing for Cancer Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Cancer Biomarkers Detection Market Research Report 2024
Global Tumor Marker Detection Market Research Report 2025
Global Tumor Marker Test Kits Market Research Report 2025
Global Tumor Marker Testing Market Research Report 2024
Global Cancer Biomarker Market Insights Forecast to 2030
Global Cancer Antigen Market Research Report 2024
Global Clinical Biomarkers Market Research Report 2024
Global Commercializing Biomarkers Market Research Report 2025
Global Oncology Biomarker Market Insights Forecast to 2030
Global Cancer Molecular Biomarkers Market Research Report 2024
Global Clinical Biomarker Testing Market Research Report 2024
Global Biomarker Market Research Report 2024
Global Alpha Fetoprotein AFP Tumor Marker Test Reagents Market Research Report 2024
Tumor Markers for Primary Liver Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tumor Markers Immunoassay Market Research Report 2024
Global Inflammatory Marker Market Research Report 2024
Global Noninvasive Cancer Biomarkers Market Research Report 2024
Global Tumor Marker Detection Products Market Insights Forecast to 2030
Global Alpha Fetoprotein Testing Reagents Market Research Report 2024
Proteomic Biomarker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions